ArticleCells2022

Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics.

Olivia M D'Annibale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.